fromSilicon Canals
9 hours agoWageningen-based Scope Biosciences lands fresh capital to advance CRISPR-based molecular diagnostics platform - Silicon Canals
Scope Biosciences has secured €6 million to advance its CRISPR-based diagnostics platform, aiming for more effective detection technology for agriculture and healthcare.
European startups